R0050/2026-03-31-02/Q002 — ACH Matrix¶
Matrix¶
| H1: All formal + most novel | H2: Formal but mostly redundant | H3: Not formal or not novel | |
|---|---|---|---|
| SRC01-E01: Legal consequence-calibrated proof | ++ | - | -- |
| SRC02-E01: Auditing sufficiency-appropriateness | ++ | - | -- |
| SRC03-E01: Bradford Hill captured by GRADE | + | ++ | - |
| SRC04-E01: FMEA RPN with detection | ++ | - | -- |
| SRC05-E01: FTA Boolean logic | + | N/A | - |
| SRC06-E01: External/internal criticism | ++ | - | -- |
| SRC07-E01: SIFT lateral reading novel; CRAAP not | + | + | - |
| SRC08-E01: OCEBM refinement of GRADE | + | ++ | - |
| SRC09-E01: CASP captured by Cochrane | + | ++ | - |
Legend:
++Strongly supports+Supports--Strongly contradicts-ContradictsN/ANot applicable to this hypothesis
Diagnosticity Analysis¶
Most Diagnostic Evidence¶
| Evidence | Why Diagnostic |
|---|---|
| SRC01-E01 | Legal consequence-calibrated thresholds clearly discriminate H1 from H2 — this concept is unambiguously absent from the reference set |
| SRC04-E01 | FMEA's detection dimension is structurally novel — no reference framework assesses error detectability |
| SRC03-E01 | Bradford Hill's overlap with GRADE discriminates H1 from H2 for this specific discipline |
Least Diagnostic Evidence¶
| Evidence | Why Non-Diagnostic |
|---|---|
| SRC05-E01 | FTA is complementary to FMEA; its novelty assessment is partially dependent on FMEA's |
| SRC09-E01 | CASP's overlap with Cochrane is expected and unsurprising |
Outcome¶
Hypothesis supported: H1 — All eight disciplines are formal, and five of eight contribute novel concepts
Hypotheses eliminated: H3 — All disciplines clearly have formal methods
Hypotheses inconclusive: H2 — Partially correct (three disciplines are redundant) but overall H1 is better supported since five contribute novelty